| 中文名 | (D(CH2)51,TYR(ME)2,ARG8)-VASOPRESSIN |
|---|---|
| 英文名 | 3-mercapto-3-methyl-butyryl-tyr(me)-phe-gln-asn-cys-pro-arg-gly-nh2 |
| 中文别名 |
(D(CH2)51,TYR(ME)2,G8)-血管加压素
化合物 (D(CH2)51,TYR(ME)2,G8)-VASOPRESSIN |
| 英文别名 |
[PMP1,TYR(ME)2]-G8-VASOPRESSIN
(beta-Mercapto-beta,beta-cyclopentamethylene-propionyl(sup 1),o-me-Tyr(sup 2),g(sup 8))-vasopressin 1-(beta-Mercapto-beta,beta-cyclopentamethylenropionic acid)-2-(o-methyl-Tyr)-gipressin (B-mercapto-B,B-cyclopentamethyl-*enropionyl1,O 3-MERCAPTO-3-METHYL-BUTYRYL-TYR(ME)-PHE-GLN-ASN-CYS-PRO-G-GLY-NH2 [PMP1,TYR(OME)2,G8] VASOPRESSIN (B-MERCAPTO-B,B-CYCLOPENTAMETHYLENROPIONYL1,0-ME-TYR2, G8)- VASOPRESSIN) [1-MERCAPTOCYCLOHEXYL]ACETYL-TYR[O-METHYL]-PHE-GLN-ASN-CYS-PRO-G-GLY-NH2 sk&f100273 N-[1-Mercaptocyclohexylacetyl]-O-methyl-L-Tyr-L-Phe-L-Glu(NH2)-L-Asp(NH2)-L-Cys-L-Pro-L-g-Gly-NH2 3-MERCAPTO-3-METHYLBUTYRYL-TYR[O-METHYL]-PHE-GLN-ASN-CYS-PRO-G-GLY-NH2 BETA-MERCAPTO-BETA,BETA-CYCLOPENTAMETHYLENE-PROPIONYL-TYR(ME)-PHE-GLN-ASN-CYS-PRO-G-GLY-NH2 [d(CH2)5,Tyr(Me)2]ginine vasopressin Avpa MANNING COMPOUND 1-(beta-Mercapto-beta,beta-cyclopentamethylenropionic acid)-2-o-methyltyrosyl-8-ginine vasopressin PMP-TYR(ME)-PHE-GLN-ASN-CYS-PRO-G-GLY-NH2, PMP1-CYS6, CYCLIC (D(Ch2)5-o-me-Tyr-g)vasopressin AVPX Aavp [D(CH2)51, TYR(ME)2, VAL4, G8]-VASOPRESSIN [DEAMINO-PEN1, O-ME-TYR2,G8]-VASOPRESSIN (D(CH2)(5/1),TYR(ME)2,G8)-VASOPRESSIN Cgp [Pmp1, Tyr(Me)2]-g8-Vasopressin (0.5 mg vial) [(3-Mercapto-3,3-pentamethylenropionic acid)1,O-Methyl-Tyr2]AVP (B-MERCAPTO-B,B-CYCLOPENTAMETHYL-*ENRO PIONYL1,O-M gipressin, (beta-mercapto)beta,beta-cyclopentamethylenropionic acid(1)-o-methyl-Tyr ginine vasopressin, beta-mercapto-(beta,beta-cyclopentamethylenropionic acid)(1)-methyl-Tyr PMP-TYR(ME)-PHE-GLN-ASN-CYS-PRO-G-GLY-NH2 (DEAMINO-PEN1,TYR(ME)2,G8)-VASOPRESSIN (d(CH)1,Tyr(Me)2,g)-Vasopressin b-Mercapto-b,b-cyclopentaMethylene-propionyl-Tyr(Me)-Phe-Gln-Asn-Cys-Pro-g-Gly-NH2 Glycinamide, N-[2-(1-mercaptocyclohexyl)acetyl]-O-methyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-aspaginyl-L-cysteinyl-L-prolyl-L-ginyl-, cyclic (1→5)-disulfide [d(CH2)5,Tyr(Me)2]AVP (d(CH),Tyr(Me),g)-Vasopressin trifluoroacetate salt vasopressin mercaptocyclohexaneacetic acid, MeTyr-8-L-g [BETA-MERCAPTO-BETA,BETA-CYCLOPENTAMETHYLENROPIONYL1,O-ME-TYR2,G8]-VASOPRESSIN N-[1-Mercaptocyclohexylacetyl]-O-methyl-L-Tyr-L-Phe-L-Gln-L-Asn-L-Cys-L-Pro-L-g-Gly-NH2 (d(CH2)51,Tyr(Me)2,A |
| 描述 | (d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin (SKF 100273) 是一种vasopressin V1 受体选择性拮抗剂。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.5 g/cm3 |
|---|---|
| 分子式 | C52H74N14O12S2 |
| 分子量 | 1151.36 |
| 精确质量 | 1150.51000 |
| PSA | 475.01000 |
| LogP | 3.52940 |
| 外观性状 | 白色冻干的粉末 |
| 折射率 | 1.695 |
| 符号 |
GHS07 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H332 |
| 个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
| 危害码 (欧洲) | Xn: Harmful; |
| 风险声明 (欧洲) | R20 |
| 安全声明 (欧洲) | 36 |
| 危险品运输编码 | NONH for all modes of transport |